. Increased intramyocellular lipid/impaired insulin sensitivity is associated with altered lipid metabolic genes in muscle of high responders to a high-fat diet. Am J Physiol Endocrinol Metab 310: E32-E40, 2016. First published October 20, 2015 doi:10.1152/ajpendo.00220.2015.-The accumulation of intramyocellular lipid (IMCL) is recognized as an important determinant of insulin resistance, and is increased by a high-fat diet (HFD). However, the effects of HFD on IMCL and insulin sensitivity are highly variable. The aim of this study was to identify the genes in muscle that are related to this inter-individual variation. Fifty healthy men were recruited for this study. Before and after HFD for 3 days, IMCL levels in the tibialis anterior were measured by 1 H magnetic resonance spectroscopy, and peripheral insulin sensitivity was evaluated by glucose infusion rate (GIR) during the euglycemic-hyperinsulinemic clamp. Subjects who showed a large increase in IMCL and a large decrease in GIR by HFD were classified as high responders (HRs), and subjects who showed a small increase in IMCL and a small decrease in GIR were classified as low responders (LRs). In five subjects from each group, the gene expression profile of the vastus lateralis muscle was analyzed by DNA microarray analysis. Before HFD, gene expression profiles related to lipid metabolism were comparable between the two groups. Gene Set Enrichment Analysis demonstrated that five gene sets related to lipid metabolism were upregulated by HFD in the HR group but not in the LR group. Changes in gene expression patterns were confirmed by qRT-PCR using more samples (LR, n ϭ 9; HR, n ϭ 11). These results suggest that IMCL accumulation/impaired insulin sensitivity after HFD is closely associated with changes in the expression of genes related to lipid metabolism in muscle. intramyocellular lipid; insulin sensitivity; high-fat diet
INSULIN RESISTANCE IN SKELETAL MUSCLE is one of the main features of type 2 diabetes and metabolic syndrome (16, 25) . Whereas the mechanisms underlying the development of insulin resistance have not been fully elucidated, previous studies demonstrated that accumulation of intracellular fat in skeletal muscle is closely linked to insulin resistance (3, 47) . Substances comprising intramyocellular lipid (IMCL), such as diacylglycerol (DG) and ceramide, activate signal transduction pathways that may induce insulin resistance in skeletal muscle (25) .
The fat content of food is a determinant of the accumulation of IMCL. Indeed, we and others have shown that a 3-day high-fat diet (HFD) in humans increases IMCL levels and impairs insulin sensitivity in skeletal muscle (3, 31) . On the other hand, both studies identified a large interindividual difference in the susceptibility to IMCL accumulation and insulin sensitivity by HFD.
Given that IMCL levels are determined by a balance between free fatty acid (FFA) influx and expenditure in skeletal muscle, increased FFA influx into muscle and/or impaired fatty acid oxidation may contribute to IMCL accumulation. For example, FFAs enter myocytes through specific fatty acid transport proteins (FATPs) together with CD36. In particular, CD36 has been considered a key molecule regulating FFA influx in muscle. It has been reported that sarcolemmal CD36 expression in skeletal muscle is high in people with insulin resistance, and expression levels are closely associated with FFA transport and lipid accumulation in muscle (11) . In addition, HFD-induced IMCL accumulation and insulin resistance were prevented in CD36 knockout mice (6) . On the other hand, several studies have pointed out the importance of mitochondrial function in IMCL accumulation and insulin sensitivity (4, 9, 12, 17, 21, 27, 28, 30) . Indeed, impaired mitochondrial activity in skeletal muscle is associated with the accumulation of IMCL and insulin resistance in elderly subjects (27) as well as in type 2 diabetic patients (12) and their offspring who have insulin resistance (4, 21, 28) . These results suggest that excess FFA influx into myocytes and impaired fatty acid oxidation due to mitochondrial dysfunction lead to the accumulation of IMCL and insulin resistance in skeletal muscle (4, 19, 36) .
Short-term HFD increases whole body fat oxidation and alters the expression levels of genes related to lipid metabolism in skeletal muscle. Although these changes are regarded as an adaptation process to HFD, they are highly variable among subjects. Indeed, Smith and colleagues showed that there was a striking degree of variability between subjects in their changes of fat oxidation by a 4-day HFD (33, 34) . In addition, previous studies demonstrated that HFD increases fat oxidation in lean subjects (8, 26 , 33, 34) but not in obese or previously obese subjects (2, 40) . Furthermore, a 5-day HFD increased the expression levels in skeletal muscle of genes related to fatty acid oxidation in lean healthy subjects but not in obese subjects (7) . These data suggest that changes in gene expression in response to HFD are important for the adaptation of skeletal muscle to HFD and that these changes may be associated with the interindividual variability of HFD on IMCL and insulin sensitivity.
Taking these findings into consideration, we hypothesized that interindividual variations of IMCL accumulation and insulin sensitivity upon HFD may be linked to interindividual variations of mitochondrial content and changes in gene expression by HFD in skeletal muscle. Thus, in this study, we provided nonobese healthy subjects with a 3-day HFD and selected the subjects who demonstrated high accumulation of IMCL and had highly impaired insulin sensitivity. Then, we investigated their clinical phenotypes, basal mitochondrial contents, and changes in the expression levels of genes related to metabolism in skeletal muscle by HFD.
MATERIALS AND METHODS
Subjects. The study subjects were 50 nonobese healthy volunteers (Table 1) . They were in good health as determined by their medical history, physical examination, and standard blood chemistry analyses. All subjects gave written informed consent for the study, which was approved by the Ethics Committee of Juntendo University.
Study design and measurement of various parameters. This study was a short-term intervention study designed to examine interindividual differences in IMCL accumulation and insulin sensitivity after HFD in nonobese subjects (31) . In addition to all the data of 37 subjects obtained in a former study (31) , we newly recruited 13 subjects and analyzed the data of the combined subjects. As in the previous study (31) , regular exercise was prohibited from 7 days before dietary intervention to the end of the study. At 7 days before dietary intervention, the mean daily physical activity level without regular exercise was estimated with an ambulatory accelerometer (Lifecorder; Suzuken, Nagoya, Japan). Then, each subject consumed a 3-day isocaloric normal-fat diet, which was followed by a 3-day HFD. All subjects were told to keep their daily physical activity at the mean daily physical activity level Ϯ 10% during dietary intervention, which was monitored by an accelerometer.
After the completion of both diet protocols, blood samples were taken after overnight fasting. A biopsy of the vastus lateralis (VL) muscle was also performed using a needle with local anesthesia in the subjects who agreed to the muscle biopsy (n ϭ 30). Muscle Fig. 1 . Percent changes in glucose infusion rate (GIR) and intramyocellular lipid (IMCL) levels after high-fat diet (HFD) in all subjects. The low responders (LR group; OE) and the high responders (HR group; ) are presented. Other subjects are expressed as gray circles. samples were immediately placed in the RNA-stabilizing reagent RNAlater (Qiagen, Hilden, Germany) and stored at Ϫ80°C. Extraction of total RNA and DNA from the muscle samples was performed as previously described (15) . Biochemical analyses of serum samples and total body fat content were analyzed as described previously (31) .
Dietary manipulation. During the intervention period, subjects were provided with packed meals prepared by a food company (Musashino Foods, Saitama, Japan). Each subject was provided a weight-maintaining 3-day isocaloric normal-fat diet (25% fat, 55% carbohydrate, 20% protein) and 3-day HFD (60% fat, 20% carbohydrate, 20% protein) (31) . The fat composition of the HFD was ϳ45% saturated, ϳ30% monounsaturated, and ϳ25% polyunsaturated fatty acid.
Proton magnetic resonance spectroscopy. IMCLs in the tibialis anterior (TA) and soleus (SOL) muscles were measured after overnight fasting by 1 H-magnetic resonance spectroscopy (MRS), as described previously (32, 37) . Resonance was quantified by reference to the methylene signal intensity (S-fat), with peaks being observed at ϳ1.25 ppm. IMCL was quantified by the S-fat and using the creatine signal at 3.0 ppm (Cre) as the reference and was expressed as the ratio relative to Cre (S-fat/Cre).
Hyperinsulinemic-euglycemic glucose clamp study. The euglycemic-hyperinsulinemic glucose clamp study (target plasma glucose level of 95 mg/dl and insulin infusion rate of 100 mU·m Ϫ2 ·min Ϫ1 ) was performed using an artificial pancreas (STG22; Nikkiso, Shizuoka, Japan), as reported previously (37) . The steady-state glucose infusion rate (GIR) was observed from 105 to 120 min after the beginning of the study and used as a marker of peripheral insulin sensitivity (32, 37) . Respiratory gases were analyzed using opencircuit auto O2 and CO2 analyzers with a hot-wire flow meter (MetaMax, Leipzig, Germany) in the fasting state and the steady state during the clamp study (31) . Metabolic flexibility was defined as the insulin-stimulated change in respiratory quotient (⌬RQ) (18) .
Classification of groups and analyses of procedures. After the completion of all measurements, the median percent change in GIR and IMCL in TA by HFD were calculated. High responders (HRs) (i.e., fat-sensitive subjects) were defined as subjects whose IMCL was increased and GIR was decreased after the HFD by more than the median percent change of each parameter. Low responders (LRs) (i.e., fat-resistant subjects) were defined as subjects whose IMCL was increased and GIR was decreased by less than the median percent change.
DNA microarray analysis. Five subjects each were randomly selected from the HR group and the LR group, and microarray analyses were conducted with RNA isolated from the muscle samples. The transcript profile of each sample was determined using the Affymetrix Human U133Plus2.0 array and standard Affymetrix protocols. The data were summarized using Genespring GX software (Agilent Technologies). The signal intensities for ␤-actin (ACTB) and glyceraldehyde-3-phosphate dehydrogenase genes were used as internal quality controls. To correct for variation between the gene chips, the signal data (.CEL files) were quantile normalized, with probe set intensities calculated and normalized using the MAS5 method. Then, genes expressed at low levels were excluded from further microarray analyses. Genes that were identified as being absent across all samples by Genespring GX were also excluded from further analyses. The gene expression profiles have been deposited in Gene Expression Omnibus under accession number GSE68231.
Analyses of DNA microarray data. Ward's hierarchical two-way classification was performed using differentially expressed genes and the subjects. Differentially expressed genes were identified by the significance analysis of microarray (SAM) procedure (42) . Gene set enrichment analysis (GSEA) was performed on each of the sample groups (35) . For the GSEA analyses, only the metabolic pathways based on the backgrounds of this study were applied. For SAM and GSEA analyses, a false discovery rate of less than 5% was considered significant, and a 1.5 cut-off value for the ratios was used in SAM; therefore, the upper cut-off value was 1.5 and the lower cut-off value was 1/1.5 ϭ 0.66.
Real-time quantitative PCR. To confirm the findings of the microarray results, gene expression levels were examined by real-time quantitative RT-PCR (qRT-PCR) in 9 subjects in the LR group and 11 subjects in the HR group, as previously described (15) . Primers were designed using Primer-Blast (National Center for Biotechnology Information).
Measurement of mitochondrial DNA content in skeletal muscle. The relative amounts of mitochondrial (mtDNA) and nuclear DNA in skeletal muscle were determined by estimating the amount of DNA encoding NADH dehydrogenase subunit 1 and that encoding lipoprotein lipase, respectively, which were calculated by TaqMan analysis as previously described (5).
Statistical analyses. All data are expressed as means Ϯ SD. Differences between two groups were tested by the Mann-Whitney U-test. The Wilcoxon signed rank test was used for comparison of paired observations. Spearman's nonparametric rank correlation coefficient was used to evaluate the correlation among metabolic parameters. Statistical significance was set at P Ͻ 0.05. 
RESULTS

Changes in GIR and regional IMCL levels after HFD and clinical characteristics of the LR and HR groups.
A significant increase in TA-IMCL and SOL-IMCL was observed by HFD (Table 1) , and there was a significant correlation between changes in TA-IMCL and SOL-IMCL (r ϭ 0.54, P ϭ 0.0001). GIR was significantly decreased by HFD (Table 1) . We also observed a negative correlation between changes in TA-IMCL and GIR by HFD (r ϭ Ϫ0.37, P Ͻ 0.01; Fig. 1 ), whereas the correlation between changes in SOL-IMCL and GIR by HFD was weak (r ϭ Ϫ0.26, P ϭ 0.07). These data suggest that change in TA-IMCL is a better predictor than change in SOL-IMCL for decreased GIR after HFD, and we hence used TA-IMCL data for further analysis.
As shown in Fig. 1 , there was high interindividual variation in the change in TA-IMCL and GIR by HFD. The median percent change of GIR by HFD was -6.04% and that of IMCL in TA was ϩ38.6%. Subjects whose IMCL was increased and GIR was decreased by more than the median percent changes of each parameter were classified as the HR group ( in Fig. 1) ; subjects whose IMCL was increased and GIR was decreased by less than the median percent change of each parameter were classified as the LR group (OE in Fig. 1 ). Table 1 shows the various clinical parameters of the subjects of the LR group and the HR group at baseline. Except for GIR levels that were significantly higher in the HR group than in the LR group (Table 1 and Fig. 2A) , the parameters were comparable between the LR group and the HR group at baseline. It is of note that the parameters were also comparable between the subgroups that consented to the muscle biopsy procedure (data not shown). After HFD, GIR levels became comparable between the two groups ( Fig. 2A and Table 1 ). Insulin sensitivity of both groups were about two times higher than that of our previous study subjects with type 2 diabetes (ϳ5.7 mg/kg/min) (37) and non-diabetic obese subjects (ϳ5.6 mg·kg Ϫ1 ·min Ϫ1 ) (32) . Thus, the GIR changes seen in the HR group were within normal insulin sensitivity levels. On the other hand, IMCL-TA after HFD in the HR group was 1.5 times higher than that in the LR group (Fig. 2B and Table 1) , and the IMCL level was slightly lower than that of our previous study subjects with type 2 diabetes (ϳ3.9 S-fat/ Cre) (37) and slightly higher than that of nondiabetic obese subjects (ϳ3.0 S-fat/Cre) (32) and endurance runners after HFD (ϳ3.2 S-fat/Cre) (38) . As a result, TA-IMCL was significantly increased and the GIR was significantly decreased by HFD in the HR group, but not in the LR group (Fig. 2, C and D, and Table 1 ).
The changes in other clinical characteristics before and after HFD are shown in Table 1 . Briefly, we observed decreased insulin and triglyceride (TG) levels in the total subjects after HFD. In addition, the ⌬RQ during the clamp study was decreased after HFD in the total subjects, whereas the fasting RQ was not altered. Changes in TG levels after HFD were still significant in the subgroups. The ⌬RQ was not significantly changed in the LR group, whereas it tended to decrease in the HR group (P ϭ 0.09). All other parameters were not significantly changed after HFD in the total subjects and the subgroups (Table 1) .
mtDNA copy number in skeletal muscle. The mtDNA copy number was comparable between the HR group and the LR group (Table 1) . Using all subjects whose mtDNA data were available (n ϭ 30), we analyzed the relationship between mtDNA copy number and changes in IMCL. However, we did not observe a statistically significant correlation between mtDNA copy number and the percent changes in IMCL-TA after HFD (r ϭ 0.42, P ϭ 0.09). Hierarchical cluster analysis of the patients. For microarray analyses, five subjects each were randomly selected from the HR group (HR1-5) and the LR group (LR1-5). Cluster analyses based on gene expression demonstrated that the gene expression patterns of the same individuals are more similar than the gene expression patterns before or after HFD in the different individuals. In addition, only HR5 was observed in a distinct cluster. In the other individuals, HR and LR subjects tended to belong to different clusters (Fig. 3) . Thus, we excluded HR5 from the more general gene expression profiling analyses of the LR and HR groups by SAM and GSEA analyses.
Gene expression profiling of skeletal muscle in the LR group and the HR group. Comparison of the gene expression profiling results of before and after HFD using the SAM procedure revealed that 89 probes (50 upregulated and 39 downregulated) were regulated by HFD in the HR group, whereas only 14 probes (5 upregulated and 9 downregulated) were regulated in the LR group (see Supplemental Table S1 , online only). No probes were regulated in both groups.
For the GSEA analyses, we applied the metabolic pathways for the comparison of gene expression between the LR group and the HR group at baseline, and found that two gene sets related to fatty acid metabolism were upregulated in the LR group compared with the HR group ( Table 2) . Comparison between before and after HFD in each group revealed that, whereas one pathway (oxidative phosphorylation fundamental pathway) was downregulated by HFD in the LR group (data not shown), five gene sets related to fatty acid metabolism were upregulated by HFD in the HR group (Table 3) .
Next, we identified specific genes from the GSEA analysis based on the ranking of P values (a false discovery rate of Ͻ10% and log2 ratio Ն 0.3). Comparison of gene expression between the HR group and the LR group at baseline revealed eight genes that were downregulated in the HR group compared with the LR group ( Table 4) . Comparison of gene expression levels between before and after HFD in each group revealed 22 genes that were upregulated by HFD in the HR group (Supplemental Table S2 ), whereas no genes were identified in the LR group.
Gene expression analyses in the LR and HR groups by qRT-PCR.
To further confirm the findings of the microarray analyses, the genes identified by microarray analyses were next examined by qRT-PCR in 9 subjects from the LR group and 11 subjects from the HR group, including HR5. In terms of gene expression between the LR group and the HR group at baseline, no differences were observed in all genes selected by the microarray analyses results (Fig. 4A and Supplemental Table  S2 for abbreviations). For the genes identified by microarray analyses that showed expression level changes by HFD in each group, significant differences could not be confirmed in the LR group by qRT-PCR. On the other hand, various genes related to fatty acid metabolism were confirmed to be increased by HFD in the HR group (Fig. 4B and Supplemental Table S2 ). Similarly, the percent changes of several gene expression levels after HFD in the HR group were significantly higher than those in the LR group (Fig. 4B) . Most of the genes that were significantly increased after HFD in the HR group, and showed significantly larger expression changes in the HR group than in the LR group, are involved in lipid metabolism in skeletal muscle.
Gene expression analyses for potential upstream regulators. Fatty acids work as ligands for the peroxisome proliferatoractivated receptors (PPARs) and increase the gene expression levels for fatty acid metabolism with PPAR␥ coactivator (PGC)-1␣ (10, 13, 23) . Thus, to further investigate upstream regulators, we evaluated gene expression levels of PGC-1␣ and PPAR␦ by RT-PCR and the analysis of microarray data, respectively. In addition to PPAR␣ expression levels (Fig. 4, A  and B) , we did not observe significant differences in the expression levels of PGC-1␣ and PPAR␦ between the LR and HR groups at baseline, and HFD did not significantly change the expression levels in each group as shown by microarray analysis ( Table 5) . Results of the qRT-PCR analysis were consistent with the microarray data, at least regarding PGC-1␣ expression levels (Fig. 5, A and B) . 
DISCUSSION
In the present study, we evaluated the effect of a 3-day HFD on IMCL levels, insulin sensitivity, and gene expression levels in muscle of nonobese healthy subjects. We observed the upregulation of a large number of lipid metabolism-related genes after HFD in the HR group and fewer in the LR group. These data suggest that IMCL accumulation/impaired insulin sensitivity after HFD is closely associated with changes in the expression of genes related to lipid metabolism in skeletal muscle.
In a rodent model, HFD upregulated the expression levels of genes related to fatty acid metabolism and mitochondrial biogenesis in skeletal muscle (10, 13, 20, 24, 41) . Because fatty acids work as ligands for the PPARs and increase the expression levels of genes involved in fatty acid metabolism (10, 13, 23) , it was hypothesized that the increased availability of fatty acids induces an increase in the capacity of muscle to oxidize fat, at least in part through their transcriptional response (10, 13, 15, 22, 23) . This response is reasonable for the adaptation of muscle to dietary fat and for an increase in its ability to metabolize and gain energy. Consistent with this hypothesis, in the present study, microarray and qRT-PCR analyses revealed that several gene sets of fatty acid metabolism were upregulated after HFD in the HR group; however, such changes were observed for fewer genes in the LR group. In addition, some of the genes identified, including ACSL1, CD36, CPT2, Table 6 . #P Ͻ 0.05, pre-HFD vs. post-HFD in the HR group; *P Ͻ 0.05 between the LR group and the HR group. Values were obtained by normalization to a housekeeping gene (ACTB). Data represent means Ϯ SD.
MLYCD, and UCP2, were reported to be positively regulated by PPAR␣ (29) . Thus, it appears that the transcriptional response observed in the HR group may be an adaptive reaction to increased IMCL accumulation.
Although the HFD enhanced the expression levels of genes related to fatty acid oxidation, IMCL levels were increased in the HR group. The reason for this is currently unknown because we did not directly measure fatty acid metabolism in the muscle. However, given that IMCL levels are determined by a balance between FFA influx and expenditure in skeletal muscle, fatty acid oxidation might not exceed fatty acid influx during HFD in the HR group. One possibility is that the increased expression levels of genes involved in fatty acid oxidation were not sufficient to increase fatty acid oxidation in the HR group. Consistently, at least in the fasting state, RQ levels were not significantly altered after HFD in the HR group. Another possibility is that the transcriptional changes in skeletal muscle by HFD might facilitate FFA influx into myocytes in the HR group. The expression levels of CD36, known as an important molecule for FFA transport and lipid accumulation in muscle (6, 11) , were enhanced after the HFD only in the HR group. Future studies are clearly required to determine the mechanisms underlying this discrepancy.
GIR levels were higher in the HR group at baseline than in the LR group. Although insulin sensitivity was decreased after HFD in the HR group, GIR levels in the HR group after HFD were almost the same as the GIR levels after HFD in the LR group or in all subjects (Table 1) . Thus, the GIR after HFD changed from a supernormal to a normal insulin sensitivity level in the HR group. In addition, transcriptional changes seen in the HR group occurred in highly insulin-sensitive states and may be different from the etiology of IMCL accumulation in insulin-resistant subjects. Recent data of muscle sample analyses revealed an interesting association between insulin sensitivity and gene expression levels in skeletal muscle. Jans et al. (14) recruited 122 subjects with metabolic syndrome, divided them into quartiles based on their insulin sensitivity, and analyzed their muscle gene expression levels. They found that skeletal muscle gene expression levels of important regulators for fat oxidation, namely, PPAR␣ and PGC-1␣, were lower in both the most insulin-sensitive group and the most insulinresistant group compared with the middle two quartiles. In addition, previous studies had demonstrated that HFD enhances fat oxidation (8, 26, 33, 34) and the expression of genes related to fat oxidation in skeletal muscle (7) in lean subjects, but not in obese or previously obese subjects (2, 7, 40) .
Together with our observations, there may be transcriptionally adaptive phases for fat oxidation from a very insulin-sensitive state toward a moderately impaired insulin sensitivity state, and the most insulin-resistant subjects may have a reduced ability to upregulate these genes (14) . This transcriptional adaptation may promote metabolic flexibility (18, 33, 34, 43, 44) and prevent further accumulation of IMCL by HFD.
Several reports demonstrated that mitochondrial content and/or activity in skeletal muscle are reduced in subjects with type 2 diabetes and insulin resistance and that a reduction in mitochondrial content and/or activity is associated with IMCL accumulation (4, 9, 12, 17, 21, 27, 28, 30 ). Although we did not observe a statistically significant link between decreased mitochondrial content in skeletal muscle and IMCL accumulation after HFD, we observed a weak correlation between these factors (r ϭ 0.42, P ϭ 0.09). The subjects of this study were healthy young men with good insulin sensitivity, and the intervention was only a 3-day HFD; thus, it is also possible that mitochondria copy number may not be a strong determinant of IMCL accumulation and insulin resistance upon HFD in this situation. It should also be noted that we only evaluated the copy number of mtDNA, which does not always indicate mitochondrial function.
Our data demonstrated a significant correlation between changes in IMCL and changes in GIR after HFD; however, the correlation coefficient was low (Fig. 1) . For example, we observed some subjects whose IMCL was increased and GIR was almost unchanged or increased. Consistently, it has been suggested that not TG, but some other specific lipids in myocytes, such as DG and ceramide, activate signal transduction pathways that may induce insulin resistance in skeletal muscle (25) . Most IMCL measured by 1 H-MRS is TG; thus, IMCL accumulation evaluated by 1 H-MRS is not always related to insulin resistance. For example, accumulation of intramyocellular TG is observed in endurance athletes, although they are highly sensitive to insulin (athlete's paradox) (12, 45) . How- ever, it has also been reported that levels of intramyocellular DGs were also markedly higher in highly trained athletes, whereas ceramide levels were similar to those in control subjects (1) . Thus, the potential mechanism linking IMCL accumulation and insulin resistance has not been fully clarified. Future studies are required to further understand the mechanism leading to subjects in the HR group being different from subjects whose IMCL is increased, but who have sustained insulin sensitivity after HFD.
Although we defined the LR and the HR groups partly by changes in TA-IMCL levels after HFD, we evaluated gene expression levels in VL because of safety reasons. Vermathen et al. (46) investigated IMCL levels in 13 different muscles, including VL, SOL, and TA, before and after aerobic exercise. They found that baseline IMCL levels for different subjects were strongly correlated between the muscle (average correlation coefficient between all muscle was r ϭ 0.83). In addition, the IMCL changes after exercise for different subjects were highly correlated among all muscles (average correlation coefficient between all muscle was r ϭ 0.76). These data suggested that a strong depletion in one muscle was generally accompanied by a strong depletion in other muscles of the same subject as well. Similarly, our data demonstrated that baseline levels of IMCL were significantly correlated between TA and SOL (r ϭ 0.40, P Ͻ 0.05). In addition, there was a significant correlation between changes in TA-IMCL and SOL-IMCL after HFD (r ϭ 0.54, P ϭ 0.0001). Although these data suggested that to some extent IMCL levels in different muscles are similarly changed by exercise and HFD, this issue should be considered a methodological limitation of the present study.
Another limitation of the present study is that we included only male subjects. It has been reported that fatty acid metabolism in skeletal muscle is different between men and women. Higher levels of IMCL were observed in female subjects than in male subjects (39) . The transcriptional response observed in the HR group appeared to be an adaptive reaction to increased IMCL accumulation. However, the HR group was defined as showing an increased IMCL and decreased GIR after HFD, and we should keep in mind that it is unclear which parameter (IMCL and/or GIR) is responsible for the changes in gene expression levels seen in the HR group. Another limitation is the small number of subjects. Because of the small number of subjects, we had to divide the subjects at the median of percent changes in IMCL and GIR after HFD. However, the cut-off value we used may not be the best point to divide the group in order to detect differences. Finally, we only applied metabolic pathways on microarray data based on the backgrounds. Further analyses are required to clarify the undetermined pathways and upstream genes associated with metabolic responses to HFD.
In conclusion, our data suggest a link between transcriptional responses in skeletal muscle and IMCL accumulation/ impaired insulin sensitivity after HFD. These data might reflect an adaptive state during IMCL accumulation and impaired insulin sensitivity during HFD.
